Alpha 2.0
Login Register
» Articles » PMID: 24449311

Improving the Drug Development Process: More Not Less Randomized Trials

Overview
Journal JAMA
Publisher American Medical Association
Specialty General Medicine
Date 2014 Jan 23
PMID 24449311
Citations 8
Authors
Benjamin Djulbegovic
Iztok Hozo
John P A Ioannidis
Affiliations
Soon will be listed here.
Citing Articles

When Null Hypothesis Significance Testing Is Unsuitable for Research: A Reassessment.

Szucs D, Ioannidis J Front Hum Neurosci. 2017; 11:390.

PMID: 28824397 PMC: 5540883. DOI: 10.3389/fnhum.2017.00390.

Timing and Characteristics of Cumulative Evidence Available on Novel Therapeutic Agents Receiving Food and Drug Administration Accelerated Approval.

Naci H, Wouters O, Gupta R, Ioannidis J Milbank Q. 2017; 95(2):261-290.

PMID: 28589600 PMC: 5461381. DOI: 10.1111/1468-0009.12261.

Precision medicine needs randomized clinical trials.

Saad E, Paoletti X, Burzykowski T, Buyse M Nat Rev Clin Oncol. 2017; 14(5):317-323.

PMID: 28169302 DOI: 10.1038/nrclinonc.2017.8.

Partnering With Patients in the Development and Lifecycle of Medicines: A Call for Action.

Hoos A, Anderson J, Boutin M, Dewulf L, Geissler J, Johnston G Ther Innov Regul Sci. 2015; 49(6):929-939.

PMID: 26539338 PMC: 4616907. DOI: 10.1177/2168479015580384.

Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa?.

Lanini S, Zumla A, Ioannidis J, Di Caro A, Krishna S, Gostin L Lancet Infect Dis. 2015; 15(6):738-45.

PMID: 25881871 PMC: 7129402. DOI: 10.1016/S1473-3099(15)70106-4.